ArticlePlastic and reconstructive surgery. Global open2026
Short- and Long-term Patency of Prophylactic and Therapeutic Lymphovenous Anastomosis for Extremity Lymphedema: A Systematic Review.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The clinical effectiveness of lymphovenous anastomosis (LVA) for extremity lymphedema often decreases after 6-12 months. This waning effect is believed to be associated with loss of anastomotic patency, but patency rates remain poorly defined in the current literature. Consequently, the goal of this systematic review is to summarize the available evidence on short- (≤12 mo) and long-term (>12 mo) patency following supermicrosurgical LVA. Methods: A preferred reporting items for systematic reviews and meta-analyses-compliant systematic literature search for lymphedema, LVA, and patency/imaging was conducted in Embase, Medline (Ovid), and Web of Science. Citation searching via Lens.org, Scopus, and Web of Science supplemented the primary search. Risk of bias was assessed using ROBINS-I and RoB-2.0 tools. Study results were tabulated and summarized narratively. Results: A total of 2011 records were screened, of which twelve observational studies and one randomized controlled trial (1089 patients) met the inclusion criteria. Short-term patency after therapeutic LVA ranged from 32% to 93% and long-term patency from 36% to 97%. Prophylactic LVA demonstrated comparable durability with a patency rate of 80% after 18 months. Importantly, studies utilizing indocyanine green lymphography consistently reported lower short-term patency rates than those using lymphoscintigraphy. The majority of studies exhibited serious risk of bias. Conclusions: Long-term patency after LVA appears achievable in a substantial proportion of patients with extremity lymphedema. However, the marked variability in reported patency rates, serious risk of bias, and heterogeneity in imaging methods and patency definitions highlights the need for standardized postoperative patency assessment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.